Search

Your search keyword '"Mocroft, Amanda"' showing total 1,626 results

Search Constraints

Start Over You searched for: Author "Mocroft, Amanda" Remove constraint Author: "Mocroft, Amanda"
1,626 results on '"Mocroft, Amanda"'

Search Results

1. Risk of tuberculosis after initiation of antiretroviral therapy among persons with HIV in Europe

3. Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts

4. Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomes

7. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

8. Chronic liver enzyme elevation and use of contemporary ARVs among persons living with HIV

9. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium

10. Observational cohort study of rilpivirine (RPV) utilization in Europe

11. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

12. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/[micro]L

13. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

14. Chronic Liver Enzyme Elevation and Use of Contemporary ARVs Among People With HIV

15. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

16. Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States

17. Chronic Liver Enzyme Elevation and Use of Contemporary ARVs Among People With HIV.

18. Heavy arv exposure and exhausted/limited arv options: predictors and clinical outcomes

19. The hepatitis C cascade of care in HIV/HCV-coinfected individuals in Europe– regional and intra-regional differences

20. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

23. Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus.

24. Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV) : Results From the Copenhagen Comorbidity in HIV Infection Study

26. Hepatitis delta infection among persons living with HIV in Europe

29. Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study

30. Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort

33. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons

34. Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting

35. Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study

39. Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study

40. Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals — Results from the EuroSIDA study

41. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

42. Hepatitis delta infection among persons living with HIV in Europe

43. Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV

46. Studies on the prognosis of patients with the Acquired Immunodeficiency Syndrome (AIDS)

48. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study

49. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

50. Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals

Catalog

Books, media, physical & digital resources